Quantcast
Last updated on April 20, 2014 at 13:20 EDT

Latest Institute of Cancer Research Stories

Missing Risk In Cancer Genetics
2014-02-16 05:21:51

redOrbit Staff & Wire Reports - Your Universe Online If a combination of genetic variants are at least partially responsible for a person’s susceptibility to common diseases, then why has research to look for those genetic causes only successfully explained a fraction of the heritable risk of developing them? That’s the question that the authors of a new PLOS Genetics study set out to answer. The study, which was led by scientists at the Institute of Cancer Research (ICR),...

Children In The EU Denied Cancer Treatments Due To Regulations
2014-02-11 14:45:11

Lee Rannals for redOrbit.com - Your Universe Online European Union (EU) regulations are causing children with cancer to go without treatments, according to the Institute of Cancer Research (ICR). Leading cancer experts said that EU rules are causing some children with cancer to be denied potentially life-saving drugs because the guidelines only allow companies to trial some drugs only in adults. The experts believe that changes to these rules could allow children access to high...

Genetic Mutation Promotes One Percent Of Cancerous Tumors
2013-12-09 05:28:31

[ Watch the Video: CUX1: Cancer’s Common Ground ] redOrbit Staff & Wire Reports - Your Universe Online Scientists have located a single gene that is at least partially responsible for the development of one percent of all cancerous tumors, according to new research appearing in the advanced online edition of the journal Nature Genetics. The gene in question is CUX1, and according to the study authors, this is the first time it has been broadly associated with the onset of...

2013-12-02 21:15:20

Scientists have described a new family of proteins that appear to play a key role in cancer and might be targets for future cancer drugs. A major new study in the journal Nature sets out the structure of the new family, called glutamate intramembrane proteases – the founding member of which plays a critical role in transforming healthy cells into cancer cells. The research, funded by Cancer Research UK and conducted by scientists at The Institute of Cancer Research, London, defined...

2013-10-09 08:26:18

MONTREAL, Oct. 9, 2013 /PRNewswire/ - Hundreds of researchers from North America, Europe, Australia and Asia have joined together in a consortium to identify the genetic basis of the five most common forms of cancer - breast, prostate, lung, ovarian and colorectal. The group, called the OncoArray Consortium, developed a new customized genotyping tool - the OncoArray - manufactured by the U.S. genomics firm Illumina, Inc. "The U.S. National Cancer Institute (NCI)-funded Genetic...

2013-08-30 12:49:41

Collagen, the stuff of ligaments and skin, and the most abundant protein in the human body, has an extraordinary role in triggering chemical signals that help protect the body from cancer, a new study reveals. Scientists at The Institute of Cancer Research, London, have uncovered a series of chemical signals sent out by collagen that appear to protect against cancer's growth. Boosting those signals could act as an effective treatment for cancers that grow in the presence of collagen,...

2013-06-18 12:30:42

TORONTO, June 18, 2013 /PRNewswire/ - In a media event held this morning, two of the world's most acclaimed cancer researchers, Drs. Tak Mak of the Princess Margaret Cancer Centre, and Dennis Slamon of the University of California, Los Angeles, shared news of a major breakthrough in the decade-long pursuit to develop a new class of "sharpshooter" cancer drugs. "Dr. Slamon and I are proud to stand shoulder-to-shoulder with our fellow scientists and the donors who believe in our...

Genetic Testing Pilot Program To Begin In The UK
2013-05-21 05:15:44

Brett Smith for redOrbit.com - Your Universe Online As part of a public-private collaboration, a UK-based charitable foundation has announced a pilot program to genetically test patients for breast and ovarian cancer. “Recent advances in methods for reading the genetic code, known as sequencing, mean that looking for gene mutations is now faster and more affordable than ever before,” according to a statement from the Wellcome Trust. “There is now an opportunity to...

2013-05-15 20:23:29

Note: This release corresponds to ASCO abstracts 5014, 5004, 5009, 5010, 5013, 5037, 5059, 9617, 9618, 5059, 8502, 7130, 8619, 8613, 8614, 7014, 7056, 7057, 8512 and electronic publication e17510 RARITAN, N.J., May 15, 2013 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced that data related to three Janssen Oncology compounds have been selected for presentation at the 49(th) Annual Meeting of the American Society of Clinical Oncology (ASCO) being held May...

‘Barcode’ Blood Test Reads Genetic Results, Helps Detect Aggressive Prostate Cancer
2012-10-09 10:00:23

Lawrence LeBlond for redOrbit.com - Your Universe Online A blood test that can read genetic results much like a ℠barcode´ has been developed by scientists at the Institute of Cancer Research (ICR) and the Royal Marsden NHS Foundation. This genetic blood test can also detect the most aggressive prostate cancers by reading particular patterns of gene activity. Research staff believe the test could eventually be used to select patients who are most in need of immediate...